Nuwellis Inc vs United States Oil ETF — how do they compare? Nuwellis Inc trades at $1.5 (market cap $522.76K), while United States Oil ETF trades at $127.67. The key difference: United States Oil ETF is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NUWE | USO | |
|---|---|---|
Market Cap | $522.76K | — |
Sector | Technology | — |
52-Week High | $220.50 | $152.96 |
52-Week Low | $1.42 | $66.17 |
Enterprise Value | -$1.29M | — |
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $1.49, down 8.59% over the past day, with a bearish technical outlook. The company reported a net loss of $17.52M in 2025, with a negative net income margin of -217.22%, though it has shown revenue growth and recent strategic expansions in pediatric care. A recent 35:1 reverse stock split was executed on June 26, 2026.
The outlook remains high-risk due to persistent losses and cash burn, but growth initiatives and new product development offer potential. Key risks include execution challenges and dependence on financing. Analyst sentiment is mixed, with a 50% buy and 50% hold rating among covered analysts.
USO trades at $117.98, down 0.75% amid bearish technical signals with 13 sell indicators versus 4 buy signals. The stock faces pressure from Middle East tensions affecting oil markets, though RSI levels suggest potential oversold conditions. Recent news highlights ongoing Strait of Hormuz deadlock and declining Strategic Petroleum Reserve levels, creating volatility in energy sector valuations.
The outlook remains cautious with technical weakness and geopolitical uncertainty weighing on sentiment. Investment opportunity exists for contrarian buyers given oversold RSI levels, but risks include prolonged Middle East tensions and oil price volatility. Fundamental analysis is limited without current financial ratios available.
Trailing returns across standard periods
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →